NeuroPace (NPCE) announced the appointment of Scott Huennekens to its board of directors, effective January 6. Huennekens currently serves as chair of the board of directors of Envista Holdings (NVST) and chair of the board of directors of Hyperfine (HYPR).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NPCE:
- NeuroPace reports sees Q4 revenue $21M-$21.5M, consensus $20.91M
- NeuroPace narrows FY24 revenue view to $79.4M-$79.9M from $78M-$80M
- NeuroPace price target raised to $14 from $9 at JPMorgan
- NeuroPace completes enrollment in RNS System IDE study
- NeuroPace price target lowered to $13 from $15 at Wells Fargo